PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases
SHANGHAI , May 30, 2024 /PRNewswire/ -- On May 23 , OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially laun ched t ...
2024-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care
ZEISS Medical Ecosystem fortifies the CIRRUS 6000 with the U.S. market's largest OCT reference database and advanced cybersecurity features. ...
2024-05-30T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research
MORRISVILLE, N.C. , May 30, 2024 /PRNewswire/ -- Metabolon , Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, ...
2024-05-30T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress
SHANGHAI , May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent ...
2024-05-30T    Banking/Financial Service   Health Care/Hospital   Medical/Pharmaceuticals 
Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone
SHENZHEN, China , May 30, 2024 /PRNewswire/ -- On the 24th of May, Kexing Biopharm (688136.SH) announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received ...
2024-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Beame Expands Global Footprint
Dr. Philip Fan J.P . ( 范榮彰博士) Spearheads Provision of Premium Dental Services ...
2024-05-30T    Health Care/Hospital   Medical/Pharmaceuticals 
Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
HEIDELBERG, Germany, May 30, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced it has received clearance of its Investigational ...
2024-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata
Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients ...
2024-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
AVELOS THERAPEUTICS ANNOUNCES KRW 17 BILLION SERIES B FUNDING ROUND, SURPASSING KRW 30 BILLION TOTAL RAISED
Stassets Investment Leads Round with Major Contribution, Joined by LSK Investment and Shinhan Capital ...
2024-05-29T    Banking/Financial Service   Medical/Pharmaceuticals 
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024
Veritas will present two pioneering studies at the European Society of Human Genetics Conference, in Berlin from June 1 to June 4 . With a focus on elective genomic screening and newborn genomic screening, ...
2024-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved